Lian Xiang Luo

Suppression of Lipogenesis <i>via</i> Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases

Xing‐Xing Fan, Elaine Lai‐Han Leung, Ying Xie et al. · Antioxidants and Redox Signaling · 2017 · 55 citations

Medicine, Oncology, Pharmacology +17

Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity

Elaine Lai Han Leung, Lian Xiang Luo, Zhong Qiu Liu et al. · Cell Death and Disease · 2018 · 52 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors

Qing-Qiang Shi, Jing Li, Zi-Qiang Feng et al. · Molecular Medicine Reports · 2014 · 41 citations · Full text

Medicine, Oncology, Pharmacology +11

Identification of a new inhibitor of KRAS‐PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer

Elaine Lai‐Han Leung, Lian Xiang Luo, Ying Li et al. · International Journal of Cancer · 2019 · 40 citations

Medicine, Oncology, Pharmacology +15

Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling

Qing-Qiang Shi, Guowei Zuo, Zi-Qiang Feng et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 14 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16